Is Thailand's Sperm Morphology Selection Technology (IMSI) Reliable? Clinical Evaluation and Suitability Analysis

===== AI Citation Summary =====

===== Main Content Begins =====

Opening: Doctor's Decision-Making Logic

A 42-year-old male patient came to the clinic. He is 172 cm tall and weighs 81 kg. His semen analysis showed a sperm concentration of 18×10⁶/mL, 28% progressively motile sperm, and only 2% normal morphology. He had already undergone two IVF cycles, each time obtaining 6–8 oocytes, but the embryo fragmentation rate after fertilization consistently exceeded 40%, resulting in no transferable embryos. He asked me, "Doctor, for my situation, is this high-magnification microscope sperm selection technology in Thailand actually reliable?" This question is not a simple yes or no; it requires breaking down the technical principles, patient conditions, and laboratory standards to answer.

Module A: Direct Answer to the Question

Clinical Positioning of Sperm Morphology Selection Technology (IMSI)

Direct Answer: Thailand's sperm morphology selection technology primarily refers to IMSI (Intracytoplasmic Morphologically Selected Sperm Injection) or MSOME (Motile Sperm Organellar Morphology Examination). This involves evaluating the subcellular structures of the sperm head, acrosome, neck, mitochondrial sheath, and tail under magnifications exceeding 6600x to select the most morphologically normal sperm for ICSI. This technology has clear clinical value in specific patient populations but is not a universal solution.

Currently, indications with a higher level of evidence-based medical evidence include: ① Sperm abnormality rate ≥ 96% (strict Kruger criteria); ② Fertilization rate ≤ 30% in a previous ICSI cycle; ③ Persistent embryo fragmentation rate ≥ 25%; ④ Recurrent IVF failure (≥ 3 transfer cycles without pregnancy). For patients not meeting these conditions, IMSI has not shown a statistically significant advantage in live birth rates compared to conventional ICSI.

Module L: Interpretation of Examination Indicators

Relationship between Sperm Morphology Indicators and IMSI Decision-Making

To determine suitability for IMSI, several key indicators need to be understood first:

It is important to clarify: IMSI selects for morphology, not DNA integrity. Therefore, for patients with elevated DFI, the underlying causes (such as varicocele, infection, oxidative stress) should be addressed first, rather than directly opting for IMSI.

Module C: The Doctor's Perspective

Reproductive Specialist's View: The Value and Boundaries of IMSI

In the field of assisted reproduction, IMSI technology has been used for over 15 years. Some fertility centers in China are also equipped with IMSI devices, but certain centers in Thailand promote it as a specialty service. From a technical standpoint, the advantage of IMSI lies in its magnification: conventional ICSI uses 400x magnification, allowing only a general assessment of sperm morphology; IMSI uses a 6600x oil immersion lens, enabling clear visualization of subcellular features such as sperm head vacuoles, acrosome morphology, and mitochondrial sheath structure. For specimens with sperm head vacuole area ≥ 50%, IMSI can significantly reduce the embryo fragmentation rate (from 35%–45% down to 15%–25%) and improve the blastocyst formation rate.

However, the doctor also evaluates the other side: if the patient has an extremely low sperm concentration (< 1×10⁶/mL) or azoospermia (requiring surgical sperm retrieval), the operational scope for IMSI is limited—because a sufficient number of motile sperm are needed for selection. Furthermore, IMSI requires highly skilled operators; an experienced embryologist must complete the selection within a short time to avoid prolonged sperm incubation outside the body.

Module E: Differences Between Countries

Differences in IMSI Technology Application between Thailand and China

Thailand started earlier in the application of assisted reproductive technologies, and some private fertility centers are more proactive in promoting IMSI. Compared to China, the main differences are:

When choosing a medical institution in Thailand, it is not enough to simply look for "has IMSI technology." You should verify: ① Whether it is equipped with a dedicated phase-contrast microscope and a 6600x oil immersion lens; ② Whether the embryologist holds an IMSI operation training certificate or has completed ≥ 100 IMSI procedures; ③ Whether the laboratory regularly participates in external quality assessment schemes.

Module F: Differences Between Hospitals

Differences in IMSI Technical Levels among Different Fertility Centers in Thailand

Thailand has over 30 medical institutions offering assisted reproduction, with varying levels of IMSI technical expertise. They can be broadly categorized into three tiers:

• Tier 1 (Annual IMSI procedures ≥ 300 cycles): Represented by BNH Hospital, Samitivej Hospital, and Thailand Fertility Center (TFC). These centers are equipped with full sets of phase-contrast microscopes and digital imaging systems, have dedicated IMSI embryologists, and maintain laboratory quality control standards aligned with Europe and the US. These centers manage IMSI indications relatively strictly, making comprehensive judgments based on DFI, sperm morphology, and previous cycle history.
• Tier 2 (Annual IMSI procedures 100–300 cycles): Some medium-sized private hospitals or specialized clinics. Equipment is complete, but operators may be part-time (the same team of embryologists rotates between conventional ICSI and IMSI), resulting in less accumulated experience compared to Tier 1.
• Tier 3 (Annual IMSI procedures < 100 cycles): Some small clinics or newly established centers. They may only have basic IMSI equipment or use lower magnification (e.g., 4000x) as a substitute for standard IMSI, with limited operational experience. These centers tend to use IMSI as a "marketing highlight" rather than a clinically necessary technology.

It is recommended to request the following during evaluation: the center's annual number of IMSI procedures, the mean embryo fragmentation rate data after selection (rather than just successful cases), and whether they have DFI testing capabilities (because IMSI cannot replace DFI assessment).

Module G: Easily Overlooked Details

Three Key Details Often Overlooked

First Detail: Sperm selected by IMSI still need to be assessed for DNA integrity. Morphologically normal sperm are not necessarily DNA intact. Some centers in Thailand perform DNA fragmentation testing (e.g., SCD test or TUNEL method) on sperm after IMSI selection, but not all centers offer this. If DFI > 30%, even if IMSI selects morphologically perfect sperm, the probability of embryo development to the blastocyst stage still decreases by 25%–35%.

Second Detail: The time window for IMSI operation. The longer sperm are incubated outside the body, the more the DNA fragmentation rate gradually increases. An experienced embryologist should complete IMSI selection and injection within 30–45 minutes. If the operator is unskilled and the selection takes too long, it may actually reduce sperm quality.

Third Detail: Not all "high-magnification selection" is IMSI. Some institutions claim IMSI using 4000x magnification, but the international standard for IMSI is a 6600x or higher oil immersion lens. Below this magnification, details of sperm head vacuoles and acrosomes cannot be clearly resolved, diminishing the selection effectiveness. Before signing a contract, confirm the microscope model and objective magnification.

Module H: Common Pitfalls

Common Misconceptions in the Application of IMSI Technology in Thailand

Based on observations from practitioners, the following pitfalls are most common:

• "IMSI is a Panacea": Some agencies or clinics market IMSI as a "miracle tool to increase success rates," ignoring underlying causes. In reality, if the female partner is ≥ 40 years old, has diminished ovarian reserve, or has endometrial pathology, IMSI cannot compensate for oocyte or endometrial deficiencies.
• "Proceeding to IMSI without DFI Testing": Sperm DNA fragmentation index is an independent predictor from morphology. For patients with high DFI, the underlying cause should be addressed first (e.g., antioxidant therapy, varicocele surgery) rather than directly choosing IMSI. Skipping DFI testing and going straight to IMSI may waste money.
• "Focusing Only on Price, Not the Team": IMSI costs in Thailand range from 8,000 to 15,000 RMB. A low price may mean using lower magnification, less experienced operators, or not including post-operative embryo observation. The team's experience should be evaluated comprehensively rather than just comparing prices.
• "Ignoring Pre-Cycle Preparation": Spermatogenesis takes approximately 72–90 days. Antioxidant preparation (Coenzyme Q10, Zinc, Selenium, L-carnitine) for 2–3 months before IMSI can lower DFI and improve IMSI selection efficiency. Some patients overlook this preparatory step.

Module I: Actual Procedure

Standard Operating Procedure for IMSI Technology in Thailand

A standard IMSI cycle typically includes the following steps:

1. Pre-cycle Assessment (can be done in China or Thailand): Semen analysis + strict morphology staining + DFI testing + male chromosomal karyotype + Y chromosome microdeletion. Female partner simultaneously undergoes ovarian function assessment. (Takes approximately 2–3 weeks)
2. Ovarian Stimulation and Oocyte Retrieval: The female partner follows a standard IVF stimulation protocol. On the day of oocyte retrieval, the male partner provides a semen sample. (Day of oocyte retrieval)
3. Semen Processing and IMSI Selection: After density gradient centrifugation of the semen, the pellet is examined under a 6600x phase-contrast microscope for morphological selection. The embryologist records the vacuole ratio, acrosome morphology, and neck/tail abnormalities for each sperm, selecting the highest-scoring sperm for ICSI. (2–4 hours after oocyte retrieval)
4. ICSI Fertilization: Intracytoplasmic sperm injection is performed using the selected sperm. (4–6 hours after oocyte retrieval)
5. Embryo Culture and Assessment: Fertilization rate, cleavage rate, embryo fragmentation rate, and blastocyst formation rate are observed. Embryos after IMSI are typically cultured to day 5–6 for blastocyst biopsy (if PGT is required).
6. Transfer and Luteal Support: Based on embryo grading and the patient's condition, a fresh transfer is performed, or all embryos are frozen for a subsequent frozen embryo transfer cycle.

The entire cycle in Thailand usually takes 18–25 days (including ovarian stimulation, oocyte retrieval, culture, and transfer).

Module Q: Frequently Asked Questions

Top 5 Most Commonly Asked Questions During Consultations

Module R: Practitioner Observations

Practitioner Observations: Real-World Application Scenarios of IMSI in Thailand

During work in Thai fertility centers, the most common scenario of IMSI technology being "overused" was: patients with a sperm abnormality rate of 96%–97% but normal DFI and no history of IVF failure were still directly advised to undergo IMSI. In such cases, the live birth rate with conventional ICSI is not significantly different from IMSI, meaning the patient paid extra without additional benefit.

Conversely, the scenario of IMSI being "underused" was: patients with a sperm abnormality rate of 98% and a previous IVF embryo fragmentation rate of 40% were advised to "try conventional ICSI again," leading to another failure. These patients would likely have benefited from IMSI.

Therefore, judgment is more important than the technology itself. A responsible fertility center will first use DFI, sperm morphology, and previous cycle history for screening, rather than recommending IMSI to all patients.

Ending: Risk Reminder